L
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Netherlands
Recent Filings
- 8-K199.4 KBLAVA Therapeutics NVNov 21, 8:00 AM ET·0001104659-25-114793
- 8-K247.9 KBLAVA Therapeutics NVNov 13, 8:40 AM ET·0001104659-25-110913
- 8-K209.5 KBLAVA Therapeutics NVNov 7, 4:09 PM ET·0001104659-25-108480
- 10-Q4.2 MBLAVA Therapeutics NVNov 6, 4:07 PM ET·0001104659-25-107725
- 8-K510.2 KBLAVA Therapeutics NVOct 17, 11:52 AM ET·0001104659-25-100317
- 8-K313.9 KBLAVA Therapeutics NVOct 2, 5:03 PM ET·0001104659-25-096152
- 8-K232.9 KBLAVA Therapeutics NVSep 30, 7:30 AM ET·0001104659-25-094744
- 8-K309.6 KBLAVA Therapeutics NVAug 14, 4:27 PM ET·0001104659-25-078654
- 10-Q3.9 MBLAVA Therapeutics NVAug 13, 5:00 PM ET·0001558370-25-011407
- 8-K1.4 MBLAVA Therapeutics NVAug 4, 7:42 AM ET·0001104659-25-073374
Insiders
10- Backstrom Jay T.Director
- Cooperatieve Gilde Healthcare IV U.A.10% Owner
- Dhingra KapilDirector
- Gilde Healthcare Holding B.V.10% Owner
- Gilde Healthcare IV Management B.V.10% Owner
- HURLY STEPHEN ADirector, Chief Executive Officer
- Kiener Peter ADirector
- Morris Charles QChief Medical Officer
- Noble JamesDirector
- Oliger Christy J.Director
Tickers
No tickers on record
Addresses
business
YALELAAN 62
UTRECHT
mailing
YALELAAN 62
UTRECHT
Former Names
- LAVA Therapeutics BV2021-03-24